AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
FINANCE
UBS pays discount for Schwab unit
The Swiss banking giant will buy the broker's institutional investment and research division for $265 mil, paying 17.5% less than what Schwab paid for it in November. Schwab is selling the Soundview unit to refocus on retail investors, while UBS will use the buy in a bid to become a leading Nasdaq trader. Schwab expects to record charges of $145 mil-$165 mil due to the sale. UBS fell 11 cents to 67.49; Schwab dipped 2 cents to 9.45.
MEDICAL
Statin study blow to Merck drug
The drug maker said a major study found high doses of its anti-cholesterol drug Zocor showed no conclusive benefits in preventing fresh cardiac problems in heart attack patients. In the study, patients were given Zocor within 4 days of the initial heart "event." Cholesterol levels didn't drop significantly more than in those given a placebo. The news could boost Pfizer, which makes the leading anti-cholesterol drug, Lipitor. It could also help sales of Vytorin, another cholesterol-lowering pill developed by Merck and Schering-Plough. Merck rose 4 cents to 44.97.
Bayer ...